CD28-mediated co-stimulation: a quantitative support for TCR signalling.
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 6×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialThe lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“CD28-induced activation of AKT upregulates glucose metabolis”
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023 · cited 1×
“This is also indicated by studies showing that CD28 ligation lowers the number of triggered TCRs that are required for a given respons”
Background
Cited by
Items 401–500 of 797
Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
Coleman, M. J., Zimmerly, K. M., & Yang, X. O. (2021) · Biomolecules · doi:10.3390/biom11101425 · Cited by 23
“Under normal circumstances, a T-cell is activated via the T-cell receptor (TCR) interaction with a cognate antigen presented by the MHC complex and the costimulatory action of CD28 binding to a B7 molecule on the surface of antigen presenting cells (APCs) [8,9].”
BackgroundId1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation
Liu, C., Wang, H.-C., Yu, S., Jin, R., Tang, H., Liu, Y.-F., Ge, Q., Sun, X.-H., & Zhang, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302554 · Cited by 20
“Considering the broad impacts of CD28 signaling on various cellular processes (48), an incomplete rescue of Treg differentiation by Id1 expression in CD28 mice is not surprising.”
BackgroundAbatacept Does Not Induce Direct Gene Expression Changes in Antigen-Presenting Cells
Carman, J., Davis, P. M., Yang, W.-P., Zhu, J., Han, C. L., He, A., Truong, A. B., Suchard, S. J., & Nadler, S. G. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9282-z · Cited by 20
“The CD28 costimulatory molecule plays an essential role in the activation of naive and, to a lesser extent, memory T cells (reviewed in [ 1 ]).”
BackgroundLaird, R. M., Wolf, B. J., Princiotta, M. F., & Hayes, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063178 · Cited by 22
Esposito, P. B., Grosjean, F., Rampino, T., Libetta, C., Gregorini, M., Fasoli, G., Marchi, G., Sileno, G., Montagna, F., & Canton, A. D. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.829470 · Cited by 22
“The CD40/CD40L pathway has also been known to induce CD80 and CD86 expression, resulting in the activation of the CD28 pathway [27].”
BackgroundSignaling Amplification at the Immunological Synapse
Viola, A., Contento, R. L., & Molon, B. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-03858-7_6 · Cited by 20
T Cells of Infants Are Mature, but Hyporeactive Due to Limited Ca2+ Influx
Schmiedeberg, K., Krause, H., Röhl, F., Hartig, R., Jorch, G., & Brunner-Weinzierl, M. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166633 · Cited by 22
Epigenetics of human T cells during the G0→G1 transitionPreprint
Smith, A., Chronis, C., Christodoulakis, M., Orr, S. J., Lea, N. C., Twine, N. A., Bhinge, A., Mufti, G. J., & Thomas, N. S. B. (2009) · Genome Research · doi:10.1101/gr.085530.108 · Cited by 25
“Costimulation via CD3 and CD28 induces signal transduction pathways that result in commitment and entry into the cell cycle, the growth cycle, and expression of T cell effector (activation) functions (Acuto and Michel 2003).”
BackgroundMathematical Modeling of T-Cell Activation Kinetic
Bidot, C., Gruy, F., Haudin, C.-S., Hentati, F. E., Guy, B., & Lambert, C. (2008) · Journal of Computational Biology · doi:10.1089/cmb.2007.0125 · Cited by 20
“The consolidated ligand recognition (2003) and Carneiro (2000), Dietrich et al. (2002) 0.012 mn induces physical changes of the TCR (K2).”
InfluentialWensveen, F. M., van Gisbergen, K. P. J. M., & Eldering, E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01156.x · Cited by 21
“The induction of IL-2 production is also an important aspect of CD28 costimulation (158), indicating a role for this pathway in the affinity regulation of CD8 T cells, similar to CD27.”
BackgroundKanagawa, N., Yanagawa, T., Nakagawa, T., Okada, N., & Nakagawa, S. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.85 · Cited by 19
Chimeric Antigen Receptors in Cancer Immuno-Gene Therapy: Current Status and Future Directions
Chicaybam, L., Sodré, A. L., & Bonamino, M. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.595855 · Cited by 21
“These effects occur due to recruitment of molecules such as PI3K, Grb2, and Lck, which, in turn, regulate the activity of crucial transcription factors such as NFκB and increase the production of IL-2 and Bcl-xL [36].”
BackgroundPalermo, B., Franzese, O., Donna, C. D., Panetta, M., Quintarelli, C., Sperduti, I., Gualtieri, N., Foddai, M. L., Proietti, E., Ferraresi, V., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1465163 · Cited by 18
Mensink, M., Verleng, L. J., Schrama, E., Janssen, G. M. C., Tjokrodirijo, R. T. N., van Veelen, P. A., Jiang, Q., Pascutti, M. F., van der Hoorn, M., Eikmans, M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172942 · Cited by 30
“This observation fits with the fact that CD28 costimulation helps to prepare T cells for cell division (51).”
Anti-inflammatory Effect of Quercetin on Picryl Chloride-induced Contact Dermatitis in BALB/c Mice
Kim, H.-J., Kim, J., Kim, S. J., Lee, S.-H., Park, Y.-S., Park, B.-K., Kim, B.-S., Kim, S.-K., Cho, S. D., Jung, J.-W., et al. (2010) · Laboratory Animal Research · doi:10.5625/lar.2010.26.1.7 · Cited by 18
Kumar, J., Habib, N., Huang, K.-W., Warwick, J., & Arasaradnam, R. (2020) · Diagnostics · doi:10.3390/diagnostics10050338 · Cited by 17
“The interaction between MHC class II to T cell receptor (TCR) and CD80/CD86 with CD28 on naive CD4+ T cells induces primary and co-stimulatory signalling, thereby activation and proliferation of CD4+ T cells [34,35].”
BackgroundActivation of cancer immunotherapy by nanomedicine
Wang, L., Xu, H., Weng, L., Sun, J., Jin, Y. H., & Xiao, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1041073 · Cited by 21
Lupino, E., Ramondetti, C., & Piccinini, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102938 · Cited by 20
“factors NFAT, AP-1, and NF-kB, which are necessary for T cell clonal expansion and differentiation (1, 2).”
BackgroundHost and Microbial Factors in Regulation of T Cells in the Intestine
Kim, C. H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00141 · Cited by 18
“For proper activation of T cells, additional signals should come from co-stimulatory receptors such as CD28 (Acuto and Michel, 2003).”
BackgroundOgawa, S., Watanabe, M., Sakurai, Y., Inutake, Y., Watanabe, S., Tai, X., & Abe, R. (2013) · International Immunology · doi:10.1093/intimm/dxt028 · Cited by 18
CD28 between tolerance and autoimmunity: the side effects of animal models
Porciello, N., Kunkl, M., & Tuosto, L. (2018) · F1000Research · doi:10.12688/f1000research.14046.1 · Cited by 20
Koizumi, S.-I., Masuko, K., Wakita, D., Tanaka, S., Mitamura, R., Kato, Y., Tabata, H., Nakahara, M., Kitamura, H., & Nishimura, T. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.05.002 · Cited by 20
“It has been indicated that CD86 and CD40 are especially important molecules for activation of Type-1 immunity [27-29].”
BackgroundTransitioning from native to synthetic receptors: broadening T-cell engineering and beyond
Li, Y., Liu, Y., & Lin, X. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01304-8 · Cited by 18
Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
Dicato, M. A., & Diederich, M. F. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201016666150505124037 · Cited by 17
Wafa, E. I., Geary, S. M., Ross, K. A., Goodman, J. T., Narasimhan, B., & Salem, A. K. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102055 · Cited by 17
Arya, A., & Arora, S. K. (2021) · Vaccines · doi:10.3390/vaccines9101058 · Cited by 17
“The prevailing qu litative model of memory formation d pends on the cytokin environment generated by APC an t ti cells [14,77].”
BackgroundCostimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand
Lim, H.-S., Cordoba, S., Dushek, O., Goyette, J., Taylor, A., Rudd, C. E., & van der Merwe, P. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500707 · Cited by 20
“For example, tyrosine phosphorylation of a conserved YMNM motif by Src family kinases (SFKs), such as Lck, leads to its binding to PI3K via the SH2 domain of its p85 subunit (7).”
Unraveling the Role of Allo-Antibodies and Transplant Injury
Matsuda, Y., & Sarwal, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00432 · Cited by 19
Could OX40 agonist antibody promote activation of the anti‐tumor immune response in gastric cancer?
Martins, M. R., dos Santos, R. L., Jatahy, K. D. N., da Matta, M. C., Batista, T. P., Júnior, J. I. C., Begnami, M. D., & Torres, L. C. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25001 · Cited by 17
“The survival and activation of T cells following antigen encounter depends on the balance between costimulatory and coinhibitory receptors.(5) OX40 is a potent costimulatory receptor that can potentiate T-cell receptor signaling on the surface of T lymphocytes, leading to their activation by a specifically recognized…”
BackgroundInfluentialGlobal analysis of dynamic changes in lipid raft proteins during T‐cell activation
Kobayashi, M., Katagiri, T., Kosako, H., Iida, N., & Hattori, S. (2007) · Electrophoresis · doi:10.1002/elps.200600675 · Cited by 17
CD28 shapes T cell receptor signaling by regulating Lck dynamics and ZAP70 activation
Raychaudhuri, K., Rangu, R., Ma, A., Alvinez, N., Tran, A. D., Pallikkuth, S., McIntire, K. M., Garvey, J. A., Yi, J., & Samelson, L. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1503018 · Cited by 16
Liu, X., Ning, J., Liu, X., & Chan, W. C. (2022) · Cancers · doi:10.3390/cancers14153716 · Cited by 17
Rodríguez, P., Carlier, Y., & Truyens, C. (2011) · Medical Microbiology and Immunology · doi:10.1007/s00430-011-0217-y · Cited by 16
“related to the particular enhancement of CD83 expression on activated cord blood DCs, a molecule reported to be important in activation of CD8 T cells [47–49] and participating, with other co-stimulatory molecules, to increase the frequency of T cell precursors [50, 51] as observed in Table 2 Cytokines produced by adu…”
BackgroundAntagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
Vanhove, B., Poirier, N., Fakhouri, F., Laurent, L., Hart, B. A. ‘., Papotto, P. H., Rizzo, L. V., Zaitsu, M., Issa, F., Wood, K. J., et al. (2017) · Antibodies · doi:10.3390/antib6040019 · Cited by 17
“It prevents CD28-mediat d signals by two major mechanisms: [1] i can act by down-regulating CD80 a d 86 on antigen presenting cells (APCs) by trans-endo ytosis, thereby altering the level of CD2 engagem t [2].”
BackgroundInfluentialHuang, Y., Sojka, D. K., & Fowell, D. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101027 · Cited by 16
“CD28 costimulatory signaling quantitatively changes TCR signaling, enhancing NF-kB and AP-1 to promote transcription and stabilizing IL-2 mRNA (6, 7).”
Tanemura, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11396 · Cited by 16
Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C
Shin, S. D., Shin, A. N., Mayagoitia, K., Siebold, L., Rubini, M., Wilson, C. G., Bellinger, D. L., & Soriano, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1663-5 · Cited by 16
Olguín-Contreras, L. F., Mendler, A. N., Popowicz, G. M., Hu, B., & Noeßner, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750478 · Cited by 16
“Ribosomal protein S6 (RPS6) is then a downstream target of mTOR activation (70, 71).”
BackgroundModulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse
González, P. A., Carreño, L. J., Céspedes, P. F., Bueno, S. M., Riedel, C. A., & Kalergis, A. M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/450291 · Cited by 17
“Most of these costimulatory molecules are known to accumulate at the IS during antigen recognition and can provide additional positive stimuli to näıve T cells for activation, altogether defining a differentiated phenotype to T cells (Figure 2(a)) [9].”
BackgroundCD28 Exerts Protective and Detrimental Effects in a Pulmonary Model of Paracoccidioidomycosis
Felonato, M., Pina, A., Bernardino, S., Loures, F. V., de Araújo, E. F., & Calich, V. L. G. (2010) · Infection and Immunity · doi:10.1128/iai.00297-10 · Cited by 16
Immune-based cancer therapies: mechanistic insights, clinical progress, and future directions
Devaraji, M., & Cheriyan, B. V. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00319-6 · Cited by 21
Biglari, S., Moghaddam, A. S., Tabatabaiefar, M. A., Sherkat, R., Youssefian, L., Saeidian, A. H., Vahidnezhad, F., Tsoi, L. C., Gudjonsson, J. E., Hakonarson, H. H., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.101028 · Cited by 19
Recent advances and progress in immunotherapy of solid cancers
Kumar, A., Emdad, L., Das, S. K., & Fisher, P. B. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.05.004 · Cited by 15
SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity
Amormino, C., Tedeschi, V., Paldino, G., Arcieri, S., Fiorillo, M. T., Paiardini, A., Tuosto, L., & Kunkl, M. (2022) · Cells · doi:10.3390/cells11162526 · Cited by 16
“To induce optimal inflammatory cytokine production, in addition to TCR, SEB also binds to CD28 [34–38], an important costimulatory molecule [39,40] that, in human T cells, triggers TCR-independent inflammatory signals [41–45].”
BackgroundTumor Derived Extracellular Vesicles Modulate Gene Expression in T cells
Pando, A., Schorl, C., Fast, L. D., & Reagan, J. L. (2022) · Gene · doi:10.1016/j.gene.2022.146920 · Cited by 15
Schirrmacher, V., Fournier, P., Beckhove, P., Lulei, M., Janke, M., & Aigner, M. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.4.777 · Cited by 15
CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells
Mitra, A., Shanthalingam, S., Sherman, H. L., Singh, K., Canakci, M., Torres, J. A., Lawlor, R. G., Ran, Y., Golde, T. E., Miele, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00735 · Cited by 15
The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis
Antunes, R. D. S., Kaski, J. C., & Dumitriu, I. E. (2011) · BioMed Research International · doi:10.1155/2012/464532 · Cited by 15
“Similarly, 4-1BBL is not restricted to APCs but was also found in human primary T cells [95].”
BackgroundInfluentialWeckbecker, G., Bruns, C., Fischer, K., Heusser, C., Li, J., Metzler, B., Morris, R. E., Nuesslein‐Hildesheim, B., Raulf, F., Wieczorek, G., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2006.00438.x · Cited by 15
Wen, R., Li, B., Wu, F., Mao, J., Azad, T., Wang, Y., Zhu, J., Zhou, X. Y., Xie, H., Qiu, X., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103859 · Cited by 16
Identification of Human Idiotype-Specific T Cells in Lymphoma and Myeloma
Weng, J., Neelapu, S. S., Woo, A. F., & Kwak, L. W. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_70 · Cited by 15
“Recent studies also have demonstrated CD28 and CD27 expression and 4-1BB ligand interaction to increase the pool of TCM cells ( Acuto and Michel 2003; Oelke et al. 2003; Topp et al. 2003).”
BackgroundZhou, S.-K., Chen, W., Shi, Z.-D., Wang, S.-P., Li, L., Wen, X., & Wang, Y.-M. (2014) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2014.03.008 · Cited by 14
“However, the complete activation of peripheral T cells is regulated by the T cell receptor complex and costimulatory signals that are provided by antigenpresenting cells such as dendritic cells.(21) For example, CD28 has an essential role in discriminating activation from tolerance signaling.”
BackgroundPertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes
Tonon, S., Badran, B. M., Benghiat, F. S., Goriely, S., Flamand, V., Willard-Gallo, K. E., Willems, F., Goldman, M., & Wit, D. D. (2006) · European Journal of Immunology · doi:10.1002/eji.200535697 · Cited by 14
Dölz, M., Hasiuk, M., Gagnon, J. D., Kornete, M., Marone, R., Bantug, G. R., Kageyama, R., Hess, C., Ansel, K. M., Seyres, D., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105372 · Cited by 14
“Thus, due to the complexity of CD28 costimulation, substantial controversy remains about the importance of various molecular mechanisms and the relative importance of quantitative versus qualitative CD28-mediated signals (Esensten et al., 2016; Acuto and Michel, 2003; Riha and Rudd, 2010; Sansom and Walker, 2013).”
Role of unusual CD4+ CD28− T cells in acute coronary syndrome
Sun, W., Zheng, L., & Huang, L. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1103-9 · Cited by 14
“Co-stimulation through the CD28 receptor controls the expression of IL-2 receptors and the production of IL-2 by activated T cells, which enable their proliferation and survival [ 6 ].”
BackgroundAnnibaldi, A., Sajeva, A., Muscolini, M., Ciccosanti, F., Corazzari, M., Piacentini, M., & Tuosto, L. (2008) · European Journal of Immunology · doi:10.1002/eji.200737854 · Cited by 14
Jeswin, J., Jeong, S.-M., Jeong, J.-M., Bae, J.-S., Kim, M., Kim, D., & Park, C. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.05.013 · Cited by 14
“Studies have shown that CD28 promotes T cell proliferation, cytokine production, cell survival, and cellular metabolism [4].”
BackgroundHuang, X., & Yang, Y. (2004) · European Journal of Immunology · doi:10.1002/eji.200324734 · Cited by 16
Zhang, L., Liu, T., Chen, M., Gao, S., Staley, C. A., Yang, L. P. H., & Zhu, L. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123437 · Cited by 15
Current Status of Immunotherapy Treatments for Pancreatic Cancer
Jiménez‐Luna, C., Prados, J. C., Ortíz, R., Melguizo, C., Torres, C., & Caba, O. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000623 · Cited by 15
Molecular mechanisms of breast cancer chemoresistance by immune checkpoints
Dastmalchi, N., Safaralizadeh, R., Baghbanzadeh, A., Hajiasgharzadeh, K., Asl, E. R., Amini, M. A., & Baradaran, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118604 · Cited by 13
Meyer, T., Oberg, H., Peters, C., Martens, I., Adam‐Klages, S., Kabelitz, D., & Wesch, D. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811407 · Cited by 13
“Moreover, NF- B and MAPK activation in T cells is influenced by the costimulatory signal of CD28, thereby controlling up-regulation of cytokines/chemokines, cell proliferation, differentiation, and cell death [27].”
BackgroundSaligan, L. N., Lukkahatai, N., Zhang, Z. J., Cheung, C. W., & Wang, X. M. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000454 · Cited by 13
Characterization of local and peripheral immune system in pregnant and nonpregnant ewes
Quirke, L. D., Maclean, P. H., Haack, N. A., Edwards, S. J., Heiser, A., & Juengel, J. L. (2021) · Journal of Animal Science · doi:10.1093/jas/skab208 · Cited by 13
“5; Acuto and Michel, 2003; Smith-Garvin et al., 2009) was associated with pregnancy status (P = 0.0401) in tissues of the reproductive tract (isthmus, ampulla, and endometrium combined).”
BackgroundInfluentialTiemeijer, B. M., Descamps, L., Hulleman, J., Sleeboom, J. J. F., & Tel, J. (2022) · Micromachines · doi:10.3390/mi13111910 · Cited by 14
“Co-stimulatory molecules provide the second signal [35,36] by binding to the CD28 receptors located in close proximity to the TCR.”
BackgroundAssociation of CD 28 and CTLA ‐4 gene polymorphisms with aggressive periodontitis in Brazilians
Silva, M. E., Moreira, P. R., da Costa, G., Saraiva, A., de Souza, P., Amormino, S., da Costa, J., Gollob, K. J., & Dutra, W. (2012) · Oral Diseases · doi:10.1111/odi.12036 · Cited by 13
Kerstan, A., Armbruster, N. S., Leverkus, M., & Hünig, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7689 · Cited by 15
Analysis of mechanism for human γδ T cell recognition of nonpeptide antigens
Yamashita, S., Tanaka, Y., Tsutsumi, S., Aburatani, H., Minato, N., & Ihara, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.100 · Cited by 13
Lü, Y., Feng, X., Wang, Z., Zou, M., Xu, Z., Liu, Q.-J., Chen, W., Ding, J., & Liu, H. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf020 · Cited by 13
“…the antigenic signal, mediated by the binding of the T cell receptor (TCR) to the antigen-major histocompatibility complex (MHC) [ 105 ]; (ii) the co-stimulatory signal, initiated by the interaction between CD28 on T cells and CD80/CD86 expressed on APCs, particularly dendritic cells (DCs) [ 106 ].”
Kim, H. J., Ji, Y. R., Kim, M. O., Yu, D. H., Shin, M. J., Yuh, H. S., Bae, K. B., Park, S. J., Yi, J. K., Kim, N. R., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.101 · Cited by 12
Liu, W., Liu, C., Wang, H., Xu, L., Zhou, J., Li, S., Cheng, Y., Zhou, R., & Zhao, L. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.09.017 · Cited by 12
Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model
Ghosh, S., He, X., Huang, W., & Lovell, J. F. (2022) · APL Bioengineering · doi:10.1063/5.0099811 · Cited by 12
Synthetic biology of cell signaling
Hansen, J., & Benenson, Y. (2015) · Natural Computing · doi:10.1007/s11047-015-9526-1 · Cited by 12
“However, they function endogenously in T cells as costimulatory receptors which in combination with T-cell receptors increases TCR-mediated T-cell activation (Acuto and Michel 2003).”
CD80/CD28 co-stimulation in human brucellosis
Skendros, P., Boura, P., Kamaria, F., & Raptopoulou‐Gigi, M. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03223.x · Cited by 12
Ott, P. A., Tary‐Lehmann, M., & Lehmann, P. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.012 · Cited by 12
“For the activation of naïve T cells the signal afforded by the extent of TCR ligation (Signal 1, a function of MHC-peptide density on the APC and of the TCR’s affinity for the peptide) and by costimulatory molecules and their ligands (Signal 2, including CD40/CD40L, CD80/86/CD28, OX40/OX40L, and 4-1BBL/4-1BB) are addi…”
BackgroundKarim, A. F., Sande, O. J., Tomechko, S. E., Ding, X., Li, M., Maxwell, S., Ewing, R. M., Harding, C. V., Rojas, R. E., Chance, M. R., et al. (2017) · PROTEOMICS · doi:10.1002/pmic.201700233 · Cited by 12
Huang, G., Liu, X., Tang, X., Du, L., Feng, W.-H., Hu, X., Zhu, L., Li, Q., & Suo, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01110 · Cited by 12
Co-stimulatory blockade as therapy for rheumatoid arthritis
Mackie, S. L., Vital, E. M. J., Ponchel, F., & Emery, P. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0029-4 · Cited by 12
Demetriou, P., Abu‐Shah, E., McCuaig, S., Mayya, V., Valvo, S., Korobchevskaya, K., Friedrich, M., Mann, E. H., Lee, L. Y. W., Starkey, T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/589440 · Cited by 12
A journey to your self: The vague definition of immune self and its practical implications
Koncz, B., Balogh, G. M., & Manczinger, M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309674121 · Cited by 11
“CD28 plays a pivotal role in promoting T cell prolif - eration and cytokine production (79).”
Shu, L., Yin, W., Zhuang, H., & Hua, Z. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.04.002 · Cited by 11
Dotsu, Y., Muraoka, D., Ogo, N., Sonoda, Y., Yasui, K., Yamaguchi, H., Yagita∥, H., Mukae, H., Asai, A., & Ikeda, H. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003958 · Cited by 11
Keller, A. M., & Borst, J. G. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.03.013 · Cited by 12
Rummel, T., Batchelder, J. M., Flaherty, P. R., LaFleur, G., Nanavati, P., Burns, J. M., & Weidanz, W. P. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5768-5774.2004 · Cited by 13
“chabaudi parasitemia may compensate for the lack of CD28 costimulation, if indeed CD28 costimulation provides quantitative support for TCR signaling, as proposed by Acuto and Michel (1).”
BackgroundThe Role of Il-12 and Type I Interferon in Governing the Magnitude of CD8 T Cell Responses
Starbeck-Miller, G. R., & Harty, J. T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15774-0_3 · Cited by 11
“In turn, cross-linking of both TCR and CD28 leads to enhanced T cell expansion and effector cytokine production relative to TCR ligation alone (Acuto and Michel 2003).”
BackgroundSpecific T-cell Activation in an Unspecific T-cell Repertoire
van den Berg, H. A., Molina-Parı́s, C., & Sewell, A. K. (2011) · Science Progress · doi:10.3184/003685011x13139280383942 · Cited by 10
“[14] Oreste Acuto and Frédérique Michel.”
T cell dysfunction in elderly ARDS patients based on miRNA and mRNA integration analysis
Mitsuyama, Y., Matsumoto, H., Togami, Y., Oda, S., Murtatsu, A., Yoshimura, J., Onishi, S., Ito, H., Ogura, H., Okuzaki, D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368446 · Cited by 10
“The CD28 family molecules include those that stimulate and those that inhibit T cell activation, such as CD28 proteins and ICOS (inducible costimulatory molecules) proteins, the latter of which include PD-1 and CTLA-4 (cytotoxic T lymphocyte antigen-4) (16).”
BackgroundLooi, C.-K., Loo, E.-M., Lim, H.-C., Chew, Y.-L., Chin, K., Cheah, S., Goh, B. H., & Mai, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1484535 · Cited by 11
“CD28 and CD134 support the long-term T cell expansion and survival (95, 96), while CD137 to enhances T cell proliferation, IL-2 production, expression of anti-apoptotic genes to inhibit activation-induced cell death (AICD), and memory T cell development (97).”
BackgroundCellular aspects of immunity involved in the development of atherosclerosis
Khalaf, K., Chamieh, M., Welc, N. A., Singh, C., Kaouk, J. L., Kaouk, A., Mackiewicz, A. A., Kaczmarek, M., & Perek, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1461535 · Cited by 11
McDonnell, A. M., Cook, A., Robinson, B. W. S., Lake, R., & Nowak, A. K. (2017) · BMC Cancer · doi:10.1186/s12885-017-3403-5 · Cited by 12
“The inducible co-stimulator molecule (ICOS), a member of the CD28 co-stimulator family, is expressed on activated T cells and is associated with antigen recognition [16, 17].”
BackgroundHoutenbos, I., Santegoets, S. J. A. M., Westers, T. M., Waisfisz, Q., Kipriyanov, S. M., Denkers, F., Scheper, R. J., de Gruijl, T. D., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.06990.x · Cited by 10
“Costimulation by CD28 drives T-cell cycle progression, induces T-cell differentiation, promotes T-cell survival and amplifies membrane proximal signalling induced by T-cell receptor (TCR) ligation (Acuto & Michel, 2003).”
BackgroundXu, C., Meng, X., Chai, P., Liu, H., Duan, Z., Tsai, Y., & Wu, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05681 · Cited by 9
Effects of the plasmid-encoded toxin of enteroaggregativeEscherichia colion focal adhesion complexes
Cappello, R. E., Estrada‐Gutiérrez, G., Irles, C., Giono-Cerezo, S., Bloch, R. J., & Nataro, J. P. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00776.x · Cited by 9
Peinert, S., Kershaw, M. H., & Prince, H. M. (2009) · Immunotherapy · doi:10.2217/imt.09.69 · Cited by 9
Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies
Schwab, R. D., Bedoya, D. M., King-Peoples, T. R., Levine, B. L., & Posey, A. D. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0146-4_15 · Cited by 10
Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?
Shintouo, C. M., Shey, R. A., Mets, T. F., Vanhamme, L., Souopgui, J., Ghogomu, S. M., & Njemini, R. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6030153 · Cited by 10
“CD28 expression is necessary for full cellular activation and proliferation upon T-cell stimulation, and loss of CD28 expression has a major impact on T-cell function [56].”
BackgroundInfluentialDistinct T cell subsets in adipose tissue are associated with obesity
Haugstøyl, M. E., Cornillet, M., Strand, K., Stiglund, N., Sun, D., Lawrence‐Archer, L., Hjellestad, I. D., Sparrelid, E., Busch, C., Hjelmesaeth, J. S., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202249990 · Cited by 12
Rudolf‐Oliveira, R. C. M., Auat, M., Cardoso, C. C., Santos‐Pirath, Í. M., Lange, B. G., da Silva, J. P., de Moraes, A. C. R., Dametto, G. C., Pirolli, M. M., Colombo, M. D. H. P., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.12.007 · Cited by 9
Molecular Regulation of Cytoskeletal Rearrangements During T Cell Signalling
Stradal, T. E. B., Pusch, R., & Kliche, S. (2006) · Springer eBooks · doi:10.1007/400_022 · Cited by 10
“This requires not only TCR-proximal signalling but also costimulation through CD28 with CD80 or CD86 (Acuto and Michel 2003; Rudd and Schneider 2003).”
BackgroundDiscordant CAR-T cell signaling: implications of divergence from physiological T cell activation
Gonzalez‐Garcia, P., Moares, N., Serrano-García, I., Fernández-Cisnal, R., Luna‐Espejo, R., Ocaña‐Cuesta, J., Yi‐He, W., Muñoz-Miranda, J. P., Gabucio, A., Fernandez-Ponce, C. M., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06857-w · Cited by 11
Metadata
- Authors
- Acuto, O., & Michel, F.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Acuto, Oreste
- ORCID
- Michel, Frédérique
- Venue
- Nature Reviews Immunology
- Published
- 2003-12
- Volume
- 3
- Issue
- 12
- Pages
- 939-951
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2055248228
- Cited by
- 775
- References
- 157
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 31 · 2023: 23 · 2022: 42 · 2021: 33 · 2020: 32 · 2019: 25 · 2018: 38 · 2017: 43 · 2016: 42 · 2015: 35 · 2014: 29 · 2013: 37 · 2012: 33
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, costimulation, T cell receptor signaling, T cell activation, naive T cells, clonal expansion, costimulatory receptors, signal amplification
- MeSH terms
- Animals, Carrier Proteins, Cell Cycle, Humans, Lymphocyte Activation, Membrane Proteins, Phosphoproteins, T-Lymphocytes, Signal Transduction, CD28 Antigens, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.